COVID-19 & Thrombosis Guidance

COVID-19 & Thrombosis Webinars

COVID-19 Articles


Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19

Background

Coronavirus Disease 2019 (COVID-19), caused by a novel coronavirus (SARS-CoV-2), is a highly contagious disease that appeared in Wuhan, Hubei province of China in December 2019. It has now spread to multiple countries through infected persons travelling mainly by air. Most of the infected patients have mild symptoms including fever, fatigue and cough. But in severe cases, patients can progress rapidly and develop the acute respiratory distress syndrome, septic shock, metabolic acidosis and coagulopathy including a disseminated intravascular coagulation (DIC).

International guidance is emerging and Thrombosis UK regularly updates and shares reviewed learning and approved guidance on how to manage thrombotic risk, coagulopathy, and DIC in patients with COVID-19.


July 2020 – Thrombosis UK endorse ISTH multinational Consensus Statement calling on the World Health Organisation (WHO) to share learning and support a systematic approach for managing venous thromboembolism in patients with COVID-19

Download the Document

British Thoracic Society Guidelines for COVID-19 VTE

Download the Document

June 2020 – LATEST UPDATE: Clinical guide for prevention, detection and management of thromboembolic disease in patients with COVID-19

Download the Document

May 2020 – ISTH: Scientific and Standardization Committee Communication:
Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in  Hospitalized Patients with COVID-19

Download the Document

Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report
CHEST Journal June 2020

June 2020 – Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report

Download the Document

Watch the Webinar

Webinar: July 2020 How should General Practice consider patients with respiratory issues in a time of COVID-19?

Chair:

Professor Ahmet Fuat

Panel:

Professor Beverley Hunt OBE, Dr Matthew Fay, Dr Katherine Hickman

In the wake of COVID-19, primary care practitioners face new challenges in managing COVID-19 positive patients presenting with respiratory issues.

This webinar is a collaboration between Thrombosis UK, Primary Care Cardiovascular Society (PCCS) and will consider: What is the pathway and action for primary care managing acute but not hospitalised thrombosis and patients late presenting with respiratory symptoms?

Presentation and discussion will include:

  • Guidance on investigating and managing respiratory issues in a patient when acutely unwell with COVID-19
  • Considerations for the management of asymptomatic / mildly unwell COVID-19 positive patients with a previous history of thrombosis
  • General management of respiratory issues during recovery from COVID-19

Webinar slides:

Prof B Hunt OBE: 'COVID-19 Natural History and Thrombotic Risk'

Dr Matthew Fay: 'How Should General Practice Consider Patients with Respiratory Issues in a time of COVID-19?'

Dr Katherine Hickman: 'How Should General Practice Consider Patients with Respiratory Issues in a time of COVID-19?'

Webinar: July 2020 Problem areas in thromboprophylaxis and COVID-19

Chair:

Dr Daniel Horner

Panel:

Prof Beverley Hunt OBE, Dr Susie Shapiro

As the UK manages the COVID-19 pandemic, this webinar will consider the natural history of COVID-19 and COVID pneumonia and the evidence available to inform decision making in the role of:

  • extended thromboprophylaxis following discharge from hospital for COVID-19,
  • when managing unwell COVID-19 patients in the community and care homes and
  • consideration when of COVID-19 positive patients who are at high risk of VTE.

Existing guidance, practice and emerging evidence will all be considered through presentations and discussion with opportunity to pose questions.

Watch the Webinar

Webinar: May 2020 Management & Learning in Thrombosis & Covid-19

Presenters:

Prof Beverley Hunt OBE, Dr Susie Shapiro & Dr Daniel Horner

As the UK manages the Covid-19 pandemic, this webinar will discuss management of thrombotic risk, diagnosis and treatment in patients diagnosed with Covid-19. Existing guidance, recent local changes in practice and emerging evidence will all be considered through presentations, discussion and with opportunity to pose questions.

Watch the Webinar


Associated Assets

Read Dr Daniel Horner's blog 'Diagnosis & Treatment of VTE in the Covid-19 era' on St Emlyn's which supports his presentation in this webinar.

VTE Prevention and Covid-19
Dr Susie Shapiro
Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
Presented 19th May 2020


Download Presentation [PDF]

Diagnosis & Treatment of VTE in Covid-19
Dr Daniel Horner
Emergency & Critical Care Medicine
Presented 19th May 2020

Presentation Coming Soon


Webinar: June 2020 Pregnancy, Thrombosis & COVID-19

Recording of live webinar held Thursday 11th June 2020

The COVID-19 pandemic has challenged learning and management of thrombosis prevention and management in COVID-19 patients.

Three international experts – Drs Jan Daru (UK), Claire McLintock (New Zealand) & Saskia Middeldorp (Netherlands chaired by Prof Beverley Hunt OBE (UK), will review evidence and discuss management of thrombotic risk, diagnosis and treatment in pregnant women diagnosed with COVID-19.

Current guidance, practice and emerging global data will all be considered through presentation and discussion.

Watch the Webinar


Associated Assets

Dr Claire McLintock, SARS-CoV-2 COVID-19 & Pregnancy - Download Presenation

Prof S Middeldorp, Prevention of VTE in Pregnancy - Download Presenation

Dr Jan Daru, COVID-19 and Pregnancy, the RCOG response - Download Presenation


Webinar: 9th April 2020 Thrombosis, Thromboprophylaxis & Coagulopathy in COVID- 19 Infections

Presenters:

Professor Marcel Levi, University College Hospital Prof. Levi will be discussing "Coagulopathy in COVID-19 Infections" during the webinar.
Professor Beverley Jane Hunt, King’s College London Prof. Hunt will be discussing "Thrombosis and Anticoagulant Management in COVID-19 Infections"

Watch the Webinar

ISTH COVID-19 and Thrombosis June 2020 ‘Ask The Expert’ with Prof Beverley Hunt OB

Additional Information:

Join the World Thrombosis Day Team as we ask Beverley Hunt, M.D., O.B.E. some of the most common questions about thrombosis and COVID-19

Watch the Interview

Webinar: 9th April 2020 Bleeding Disorders & Covid-19

Additional Information:

Listen as Glenn Pierce, MD, PhD (WFH VP Medical), Flora Peyvandi, MD, PhD, Magdy El Ekiaby, MD, Cedric Hermans, MD, PhD, and Radoslaw Kaczmarek, PhD, provide the global bleeding disorders community with up-to-date information on COVID-19. This 1-hour webinar, presented on April 9, 2020, also addressed participants’ questions and concerns.

Watch the Webinar

Journal Spotting Podcast: #14 JournalChat// Bloody COVID, with Thrombosis Expert Prof Beverley Hunt

Listen to this podcast via Spotify and Apple Podcast or visit the website: www.JournalSpotting.com to view other available platforms.

You can also see view the associated animation by clicking here.

NEWS: Coronavirus, ‘baffling’ observations from the front line

When you talk to intensive care doctors across the UK, exhausted after weeks of dealing with the ravages of Covid-19, the phrase that emerges time after time is, "We've never seen anything like this before."

Read the Article

NEWS: Covid-19 and thrombosis: what do we know about the risks and treatment?

Prof Hunt OBE, Medical Director for Thrombosis UK, discusses the high rates of blood clots being seen in patients who are seriously ill with covid-19, and the urgent need for the delayed clinical guidance on thrombosis and critical care for patients with Covid-19, to be published.

Read the Article

NEWS: COVID-19: Anticoagulation Recommended Even After Discharge

Guidance from consensus group and others details on use across settings

Of COVID-19's hallmark symptoms, clotting may not rank high in the national consciousness. But it has made quite an impression in-hospital. "I have never, ever, ever seen such high levels of D-dimer in any of the hundreds of other patients with venous thrombosis that I've seen over the past 15 years," said Behnood Bikdeli, MD, of NewYork-Presbyterian Hospital/Columbia University Irving Medical Center in New York City. "It's just mind-blowing."



Read the Article